Streetbeat News

Stock Prices

BAX

DVA

FMS

ISRG

Shares of dialysis providers and kidney care stocks are trading lower after Novo Nordisk stopped its semaglutide kidney outcomes trial early based on early signs of efficacy. Companies potentially affected include BAX, DVA, FMS, and ISRG.

Portfolio Pulse from Bill Haddad

October 11, 2023 | 3:03 pm

TPST

Shares of Tempest Therapeutics (TPST) have resumed trading after being halted on a circuit breaker due to a significant increase in stock price. The stock is now up by 1067.2%.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 3:02 pm

JBL

Raymond James has maintained a Strong Buy rating on Jabil's stock and increased its price target from $120 to $160. This has led to Jabil's shares trading higher.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 3:02 pm

PPG

In the last quarter, PPG Indus (NYSE:PPG) received a mix of bullish, somewhat bullish, and indifferent ratings from analysts. The average price target for the stock is $160.4, which is higher than its current price of $131.49. This average has increased by 3.68% from the previous average price target of $154.70.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 3:00 pm

CERT

Analysts have provided various ratings for Certara (NASDAQ:CERT) within the last quarter, with 1 bullish, 2 somewhat bullish, and 4 indifferent. The company has an average price target of $50.71, representing an 11.16% decrease from the previous average price target of $57.08.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 3:00 pm

TFX

Over the past 3 months, 6 analysts have published their opinion on Teleflex (NYSE:TFX) stock. The analysts have an average price target of $286.0 versus the current price of Teleflex at $198.0, implying upside. This current average represents a 0.14% decrease from the previous average price target of $286.40.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 3:00 pm

BIIB

In the last quarter, Biogen (NASDAQ:BIIB) received 24 analyst ratings, with 21 being bullish or somewhat bullish, and 3 indifferent. The average 12-month price target for the company is $333.33, a 2.26% decrease from the previous average of $341.05.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 3:00 pm

CSX

Over the past 3 months, 16 analysts have published their opinion on CSX (NASDAQ:CSX) stock. The average price target for CSX is $36.0 with a high of $40.00 and a low of $25.00. This average price target has increased by 1.29% over the past month.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 3:00 pm

BAM

Brookfield Asset Mgmt (NYSE:BAM) has received mixed analyst ratings in the last quarter, with 1 bullish, 1 somewhat bullish, and 3 indifferent. The company's average price target has increased by 12.94% from the previous average of $34.00 to $38.4.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 3:00 pm

AVAXUSD

Cryptocurrency Avalanche (AVAX) has seen a decrease of 3.27% in its price over the past 24 hours, continuing a downward trend of -2.0% over the past week. The trading volume for the coin has decreased by 20.0% over the past week, while the overall circulating supply of the coin has decreased by 0.56% to over 354.57 million. The current market cap ranking for AVAX is #23 at $3.33 billion.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 3:00 pm